ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.637,53
0,93%
S&P 500
6.039,31
-0,47%
Dow Jones
44.713,52
-0,31%
Euro vs US Dollar
1,04119
-0,12%
Bitcoin
105.030,44
1,25%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. HilleVax Inc (HLVX) Börsenkurse

HilleVax Inc

HilleVax Inc (HLVX)

NASDAQ
1,95
0,01
(0,52%)
Geschlossen 30 Januar 10:00PM
Verzögert um 15 Minuten
1,955
0,005
(0,26%)
Nach Börsenschluss: 1:59AM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
1,95
Gebot
1,85
Fragen
2,02
Volumen
144.451
1,92 Tagesbereich 1,99
1,55 52-Wochen-Bereich 20,22
Marktkapitalisierung
97,122M
Handelsende
1,94
Handelsbeginn
1,93
Letzte Trade
728
@
1.95
(priorref)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 281.865
VWAP
1,9513
Durchschnittliches Volumen (3 Mio.)
252.093
Ausgegebene Aktien
49.806.070
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,79
Gewinn pro Aktie (EPS)
-2,48
Erlöse
-
Nettogewinn
-123,57M

Über HilleVax Inc

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.hillevax.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
HilleVax Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker HLVX. The last closing price for HilleVax was US$1,94. Over the last year, HilleVax shares have traded in a share price range of US$ 1,55 to US$ 20,22.

HilleVax currently has 49.806.070 shares in issue. The market capitalisation of HilleVax is US$96,62 million. HilleVax has a price to earnings ratio (PE ratio) of -0.79.

HLVX Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

05 Dezember 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 November 2024
Edgar (US Regulatory)

HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress

$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...

07 November 2024
GlobeNewswire Inc.

Form 8-K - Current report

16 Oktober 2024
Edgar (US Regulatory)

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus...

09 August 2024
GlobeNewswire Inc.

Form 8-K - Current report

31 Juli 2024
Edgar (US Regulatory)

HilleVax Announces Reduction in Force

BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a...

31 Juli 2024
GlobeNewswire Inc.

Form 8-K - Current report

23 Juli 2024
Edgar (US Regulatory)

Form 8-K - Current report

08 Juli 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.042.09424083771.9121.891063811.9406211CS
4-0.115-5.569007263922.0652.151.872302702.01272489CS
120.021.036269430051.932.151.782520931.95665237CS
260.063.17460317461.892.151.582888091.85718529CS
52-13.41-87.304687515.3620.221.554242844.06162828CS
156-16.81-89.6055437118.7624.421.552160977.18120427CS
260-16.81-89.6055437118.7624.421.552160977.18120427CS

HLVX - Frequently Asked Questions (FAQ)

What is the current HilleVax share price?
The current share price of HilleVax is US$ 1,95
How many HilleVax shares are in issue?
HilleVax has 49.806.070 shares in issue
What is the market cap of HilleVax?
The market capitalisation of HilleVax is USD 96,62M
What is the 1 year trading range for HilleVax share price?
HilleVax has traded in the range of US$ 1,55 to US$ 20,22 during the past year
What is the PE ratio of HilleVax?
The price to earnings ratio of HilleVax is -0,79
What is the reporting currency for HilleVax?
HilleVax reports financial results in USD
What is the latest annual profit for HilleVax?
The latest annual profit of HilleVax is USD -123,57M
What is the registered address of HilleVax?
The registered address for HilleVax is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the HilleVax website address?
The website address for HilleVax is www.hillevax.com
Which industry sector does HilleVax operate in?
HilleVax operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DGNXDiginex Ltd
US$ 49,18
(228,09%)
3,34M
SLXNSilexion Therapeutics Corporation
US$ 3,1301
(131,86%)
330,45M
KRKR36Kr Holdings Inc
US$ 9,10
(114,12%)
23,61M
SPGCSacks Parente Golf Inc
US$ 0,6001
(57,92%)
52,17M
XFORX4 Pharmaceuticals Inc
US$ 0,7542
(56,54%)
42,5M
ZKINZK International Group Co Ltd
US$ 0,4813
(-41,21%)
3,1M
MGOLMGO Global Inc
US$ 0,1019
(-38,73%)
70,52M
BACKIMAC Holdings Inc
US$ 0,7869
(-35,50%)
2,37M
EYENEyenovia Inc
US$ 0,03695
(-35,18%)
25,31M
HAOHaoxi Health Technology Ltd
US$ 2,52
(-31,89%)
484,94k
NVDANVIDIA Corporation
US$ 123,70
(-4,10%)
466,94M
SLXNSilexion Therapeutics Corporation
US$ 3,1301
(131,86%)
330,45M
OCEAOcean Biomedical Inc
US$ 0,249929
(-24,26%)
186,52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,428
(-6,98%)
148,12M
RIMEAlgorhythm Holdings Inc
US$ 0,0259
(-16,18%)
138,96M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
HLVX
HilleVax
BIT
UB5N5B
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten